Key Sessions
Dave Moore
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
Novo Nordisk
Jim MacKrell
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
Eli Lilly
Elizabeth Garner
Navigating the USA Landscape for Gender Equality in Women's Health
Ferring Pharmaceuticals
Tadaaki Taniguchi
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
Astellas Pharma
Carla Peron
Sustained Success - A Holistic Review of MedTech in 2024
Philips
Ziv Bar-Joseph
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
Sanofi
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Formats
Showing 1 of 1 Streams
BIOTECH LEADERS MORNING KEYNOTE PLENARY
9:00am - 9:05am
LSX Welcome Address
- Adam Griffiths - Senior Director, Biotech Lead, Informa
9:05am - 9:30am
Assessing Biotech Investment Trends in 2024 and Beyond
9:30am - 10:10am
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
- Jim MacKrell - VP Lilly Venture Science, Eli Lilly
- Issi Rozen - General Partner, Google Ventures
- Richard Kivel - CEO, Graybella Capital
- Bibhash Mukhopadhyay - Managing Partner & Co-Founder, Sound Bioventures
- Chris Jeffers - SVP, Life Sciences, Brown Rudnick
10:10am - 10:30am
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
- Tadaaki Taniguchi - Chief Medical Officer, Astellas Pharma
Showing 3 of 3 Streams
CAPITAL MARKETS & INVESTMENT
PARTNERSHIPS & DEAL MAKING
SCALING & COMMERCIALISATION
11:00am - 11:50am
The Venture Investor Outlook and Investing in the Therapies of Tomorrow
- Jeff Quillen - Partner, Foley Hoag
- Dirk Landgraf - Partner, SV Health Investors
- Evan Caplan - Principal, OrbiMed
- Eric Snyder - Partner, Venture Investments, Novo Holdings
- Rebecca Luse - Principal, Deep Track Capital
- Ralf Saykiewicz - Managing Partner, Raudi Capital
11:50am - 12:40pm
Understanding Shifts in Early-Stage VC Investment Criteria
- Stephen Bruso - Partner, Morningside Advisory
- John Boyce - Managing Director & Co-Founder, TigerGene
- Soyoung Park - Managing Director, 2080 Ventures
11:00am - 11:40am
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
- Hannah England - Partner, Ropes & Gray
- Garrett Rhyasen - VP, Head of Search, Evaluation, & Transactions, GSK
- Jeremy O’Hanlon - Executive Director, Global BD, Daiichi-Sankyo
- Alison Hogg - Executive Director, Corporate Development, Gilead Sciences
- Hong Chen - Director, Search & Evaluation USA, Novo Nordisk
11:40am - 12:00pm
Driving Innovation in Life Sciences Through Fostering Strong Partnerships Between Industry, Academia, and NPOs
- Andrew Whittle - Director, Strategic Partnering, Cardiometabolism & Retinal Health, Boehringer Ingelheim
12:00pm - 12:40pm
Driving Innovation in Life Sciences Through Fostering Strong Partnerships Between Industry, Academia, and NPOs
- Alison Fenney - Executive Director, Strategic Partnerships and Business Operations, Regeneron Genetics Center
- Alfred Slanetz - Chairman, National Foundation for Cancer Research
- James Zanewicz - Chief Strategy Officer, Tulane University
- Peter Meinke - Sanders Director, Tri-Institutional Therapeutics Discovery Institute
11:00am - 11:40am
Funding Biotech Innovation and Scaling Up
- Ellen Donnelly - CEO, Abliva
- Ann Belien - CEO & Founder, Rejuvenate Biomed
- Matt Britz - CEO, AffyImmune Therapeutics
- Dan Passeri - CEO, Cue Biopharma
- Rachel Ravens - CEO, 42Genetics
11:40am - 12:00pm
Accelerating Cures: Speeding Up Clinical Trials to Maximize Returns For All
- Ben van der Schaaf - Partner, Arthur D. Little
- Ben Enejo - Partner, Arthur D. Little
12:00pm - 12:40pm
Integrating CMC Development for Value Creation in Biotech Start-Ups
- Christelle Dagoneau - Vice President, Head of Business Development - Product Development Solutions, ProductLife Group
- Neera Jain - Vice President, Chemical Pharmaceutical Development & Operations, Syros Pharmaceuticals
- Keir Loiacono - CEO, BlueSphere Bio
- Johannes Roebers - General Manager, Cilatus
Showing 3 of 3 Streams
CAPITAL MARKETS & INVESTMENT
PARTNERSHIPS & DEAL MAKING
SCALING & COMMERCIALISATION
1:40pm - 2:30pm
Building Strong Biotech Foundations: Governance, Growth, and Fundraising Strategies
- Regina Salvat - Principal, Sofinnova Investments
- Michael Goldberg - CEO, Surge Therapeutics
- Elaine Yang - Director, ORI Capital
2:30pm - 3:20pm
The CVC Perspective: Strategic Venturing in Biotech Throughout 2024 & Beyond
- Marian Nakada - VP, Venture Investments, JJDC
- Aaron Nelson - Managing Director, Novartis Venture Fund
- Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
1:40pm - 2:30pm
The Oncology Odyssey: Exploring New Market Trends In Cancer Research and Partnering
- Jenny Wang - Director, S&E Oncology, AbbVie
- Natalia Ulyanova - Business Development Director, Oncology, Astellas, USA
2:30pm - 3:20pm
Navigating the USA Landscape for Gender Equality in Women's Health
- Elizabeth Garner - CSO, Ferring Pharmaceuticals
- Elizabeth Bailey - Managing Director, RH Capital
- Carolee Lee - CEO & Founder, WHAM
1:40pm - 2:30pm
Commercialization Strategies for Biotechs and Early-Planning
- Joe Goldberg - Partner, RSM US LLP
- Dan Oliver - CEO, Rejuvenate Bio
- Michelle Chen - CBO, Insilico Medicine
- Jeff Landau - CBO, CytomX
- Sohail Zaidi - CEO, Ananda Scientific
2:30pm - 3:20pm
Developing an Effective Message and Strategic Positioning in a Crowded Market
- David Brower - CBO, Accent Therapeutics
- Daniel Silva Manzano - CEO, Monod Bio
- Jae Won Kim - COO & CFO, VantAI
- Kimberly Ha - Founder & CEO, KKH Advisors
Showing 1 of 1 Streams
BIOTECH LEADERS AFTERNOON KEYNOTE PLENARY
3:50pm - 4:30pm
Maximizing Returns: Unleashing the Power of AI for Tangible ROI
- Kamni Vijay - CEO, Enable Medicine
- Mark Stead - Head of BD, Atomic AI
- Greg Ryslik - CTO, COMPASS Pathways
- Elizabeth Schwarzbach - CBO, BigHat Biosciences
- Ben Hohn - Principal, BD, Pipeline and Launch Strategy, ZS Associates
4:30pm - 4:50pm
Chiesi Company Presentation
4:50pm - 5:30pm
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
- Dave Moore - EVP, Coporate Development, Novo Nordisk
- Sarah Kilpatrick - VP Business Development, Pfizer
- Philippe Lopes-Fernandes - EVP, CBO, Ipsen
- Issei Tsukamoto - SVP, Global Head Business Development, Astellas
- Michelle Li - Vice President and Head, BD&L Transactions, Bristol Myers Squibb
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats